D.A. Davidson & Co’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-7,560
Closed -$373K 1136
2019
Q1
$373K Buy
+7,560
New +$340K 0.01% 785
2018
Q4
Sell
-4,512
Closed -$230K 1163
2018
Q3
$230K Buy
+4,512
New +$200K ﹤0.01% 1022
2017
Q3
Sell
-10,684
Closed -$313K 1894
2017
Q2
$313K Sell
10,684
-264
-2% -$7.22K 0.01% 779
2017
Q1
$278K Sell
10,948
-12,204
-53% -$315K 0.01% 811
2016
Q4
$591K Buy
23,152
+64
+0.3% +$1.68K 0.01% 607
2016
Q3
$628K Sell
23,088
-524
-2% -$14.4K 0.02% 572
2016
Q2
$664K Sell
23,612
-428
-2% -$11K 0.02% 482
2016
Q1
$566K Buy
24,040
+740
+3% +$16.3K 0.02% 498
2015
Q4
$521K Sell
23,300
-100
-0.4% -$2.28K 0.02% 530
2015
Q3
$538K Sell
23,400
-1,872
-7% -$46.9K 0.02% 512
2015
Q2
$619K Sell
25,272
-1,512
-6% -$37.8K 0.02% 520
2015
Q1
$669K Buy
26,784
+256
+1% +$6.09K 0.02% 500
2014
Q4
$611K Sell
26,528
-2,896
-10% -$66.3K 0.02% 526
2014
Q3
$686K Sell
29,424
-620
-2% -$14.5K 0.02% 503
2014
Q2
$692K Sell
30,044
-2,576
-8% -$56.9K 0.02% 513
2014
Q1
$694K Buy
32,620
+3,604
+12% +$81.1K 0.02% 511
2013
Q4
$685K Sell
29,016
-2,348
-7% -$50.9K 0.03% 510
2013
Q3
$626K Sell
31,364
-1,112
-3% -$21.1K 0.03% 448
2013
Q2
$558K Buy
+32,476
New +$539K 0.03% 449

Other funds holding TECH

D.A. Davidson & Co's TECH Position: Q2 2019 in Review

D.A. Davidson & Co sold out of Bio-Techne (TECH) in Q2 2019, closing a stake of 7,560 shares — an estimated $373K sold.

D.A. Davidson & Co first reported a position in TECH in Q2 2013 and held it in 19 quarters. The position peaked at $694K in Q1 2014. 369 funds tracked by Wall St. Rank hold TECH as of Q2 2019.

  • D.A. Davidson & Co reported no remaining Bio-Techne position as of Q2 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 7,560 Bio-Techne shares in Q2 2019, an estimated $373K.
  • D.A. Davidson & Co first reported a position in Bio-Techne in Q2 2013 and held it in 19 quarters.
  • D.A. Davidson & Co's Bio-Techne position peaked at $694K in Q1 2014.
  • 369 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.